MedPath

Effect of product on hair growth

Not Applicable
Registration Number
CTRI/2024/08/072137
Lead Sponsor
Mountain valley springs India pvt. ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Indian / Asian male & female subjects.

2.Healthy subjects

3.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)

4.Having androgenetic alopecia of class I-2 to I-4 according to Ludwig Scale for females and class II to III (including III, IIIA and IIIvertex) according to Norwood Hamilton Scale for males.

Exclusion Criteria

1.For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months

2.Having refused to give his/her assent by not signing the consent form

3.Taking part in another study liable to interfere with this study

4.Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area

5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)

6.Having a progressive asthma (either under treatment or last fit in the last 2 years)

7.Being epileptic

8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)

9.Having cutaneous hypersensitivity

10.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products

11.Following a chronic or intermittent medicinal treatment comprising any of the following products:aspirin-based products, anti-inflammatories, antihistamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)

12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in hair growth i.e. improvement in A:T ratioTimepoint: Baseline, Day 28, Day 56, Day 84
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath